RESUMO
Despite the contribution of changes in pancreatic ß-cell mass to the development of all forms of diabetes mellitus, few robust approaches currently exist to monitor these changes prospectively in vivo. Although magnetic-resonance imaging (MRI) provides a potentially useful technique, targeting MRI-active probes to the ß cell has proved challenging. Zinc ions are highly concentrated in the secretory granule, but they are relatively less abundant in the exocrine pancreas and in other tissues. We have therefore developed functional dual-modal probes based on transition-metal chelates capable of binding zinc. The first of these, Gdâ 1, binds Zn(II) directly by means of an amidoquinoline moiety (AQA), thus causing a large ratiometric Stokes shift in the fluorescence from λem =410 to 500â nm with an increase in relaxivity from r1 =4.2 up to 4.9â mM(-1) s(-1) . The probe is efficiently accumulated into secretory granules in ß-cell-derived lines and isolated islets, but more poorly by non-endocrine cells, and leads to a reduction in T1 in human islets. In vivo murine studies of Gdâ 1 have shown accumulation of the probe in the pancreas with increased signal intensity over 140â minutes.
Assuntos
Diabetes Mellitus/diagnóstico por imagem , Diagnóstico por Imagem/métodos , Células Secretoras de Insulina/diagnóstico por imagem , Elementos da Série dos Lantanídeos/química , Espectroscopia de Ressonância Magnética/métodos , Zinco/química , Animais , Células HEK293 , Humanos , Camundongos , Estrutura Molecular , RadiografiaRESUMO
BACKGROUND: The additive effects of obesity and metabolic syndrome on left ventricular (LV) maladaptive remodeling and function in hypertension are not characterized. METHODS: We compared an obese spontaneously hypertensive rat model (SHR-ob) with lean spontaneously hypertensive rats (SHR-lean) and normotensive controls (Ctr). LV-function was investigated by cardiac magnetic resonance imaging and invasive LV-pressure measurements. LV-interstitial fibrosis was quantified and protein levels of phospholamban (PLB), Serca2a and glucose transporters (GLUT1 and GLUT4) were determined by immunohistochemistry. RESULTS: Systolic blood pressure was similar in SHR-lean and SHR-ob (252 ± 7 vs. 242 ± 7 mmHg, p = 0.398) but was higher when compared to Ctr (155 ± 2 mmHg, p < 0.01 for both). Compared to SHR-lean and Ctr, SHR-ob showed impaired glucose tolerance and increased body-weight. In SHR-ob, LV-ejection fraction was impaired vs. Ctr (46.2 ± 1.1 vs. 59.6 ± 1.9%, p = 0.007). LV-enddiastolic pressure was more increased in SHR-ob than in SHR-lean (21.5 ± 4.1 vs. 5.9 ± 0.81 mmHg, p = 0.0002) when compared to Ctr (4.3 ± 1.1 mmHg, p < 0.0001 for both), respectively. Increased LV-fibrosis together with increased myocyte diameters and ANF gene expression in SHR-ob were associated with increased GLUT1-protein levels in SHR-ob suggestive for an upregulation of the GLUT1/ANF-axis. Serca2a-protein levels were decreased in SHR-lean but not altered in SHR-ob compared to Ctr. PLB-phosphorylation was not altered. CONCLUSION: In addition to hypertension alone, metabolic syndrome and obesity adds to the myocardial phenotype by aggravating diastolic dysfunction and a progression towards systolic dysfunction. SHR-ob may be a useful model to develop new interventional and pharmacological treatment strategies for hypertensive heart disease and metabolic disorders.
Assuntos
Obesidade/complicações , Disfunção Ventricular Esquerda/complicações , Remodelação Ventricular , Animais , Pressão Sanguínea , Cálcio/metabolismo , Perfilação da Expressão Gênica , Hemodinâmica , Imageamento por Ressonância Magnética , Masculino , Obesidade/fisiopatologia , Ratos , Ratos Endogâmicos SHR , Disfunção Ventricular Esquerda/genética , Disfunção Ventricular Esquerda/fisiopatologia , Remodelação Ventricular/genéticaRESUMO
Near-infrared fluorophore (NIRF)-labeled imaging probes are becoming increasingly important in bio-molecular imaging applications, that is, in animal models for tumor imaging or inflammation studies. In this study we showed that the previously introduced chemical concept of 'Reverse Design' represents an efficient strategy for the generation of selective probes for cysteine proteases from chemically optimized protease inhibitors for investigations in proteomic lysates as well as for in vivo molecular imaging studies. The newly developed activity-based probe AW-091 was demonstrated to be highly selective for cathepsin S in vitro and proved useful in monitoring cysteine cathepsin activity in vivo, that is, in zymosan-induced mouse model of inflammation. AW-091 showed higher signal-to-background ratios at earlier time points than the commercially available polymer-based ProSense680 (VisEn Medical) and thus represents an efficient new tool for studying early proteolytic processes leading to various diseases, including inflammation, cancer, and rheumatoid arthritis. In addition, the fluorescent signal originating from the cleaved AW-091 was shown to be reduced by the administration of an anti-inflammatory drug, dexamethasone and by the cathepsin inhibitor E-64, providing a valuable system for the evaluation of small-molecule inhibitors of cathepsins.
Assuntos
Catepsinas/metabolismo , Cisteína Proteases/metabolismo , Corantes Fluorescentes , Indóis/síntese química , Inflamação/enzimologia , Fenazinas/síntese química , Animais , Anti-Inflamatórios/farmacologia , Inibidores de Cisteína Proteinase/síntese química , Inibidores de Cisteína Proteinase/química , Inibidores de Cisteína Proteinase/metabolismo , Dexametasona/farmacologia , Modelos Animais de Doenças , Corantes Fluorescentes/síntese química , Corantes Fluorescentes/metabolismo , Indóis/metabolismo , Inflamação/induzido quimicamente , Leucina/análogos & derivados , Leucina/metabolismo , Masculino , Camundongos , Fenazinas/metabolismo , ZimosanRESUMO
BACKGROUND: Many translational MR biomarkers derive from measurements of the water proton longitudinal relaxation rate R1, but evidence for between-site reproducibility of R1 in small-animal MRI is lacking. OBJECTIVE: To assess R1 repeatability and multi-site reproducibility in phantoms for preclinical MRI. METHODS: R1 was measured by saturation recovery in 2% agarose phantoms with five nickel chloride concentrations in 12 magnets at 5 field strengths in 11 centres on two different occasions within 1-13â¯days. R1 was analysed in three different regions of interest, giving 360 measurements in total. Root-mean-square repeatability and reproducibility coefficients of variation (CoV) were calculated. Propagation of reproducibility errors into 21 translational MR measurements and biomarkers was estimated. Relaxivities were calculated. Dynamic signal stability was also measured. RESULTS: CoV for day-to-day repeatability (Nâ¯=â¯180 regions of interest) was 2.34% and for between-centre reproducibility (Nâ¯=â¯9 centres) was 1.43%. Mostly, these do not propagate to biologically significant between-centre error, although a few R1-based MR biomarkers were found to be quite sensitive even to such small errors in R1, notably in myocardial fibrosis, in white matter, and in oxygen-enhanced MRI. The relaxivity of aqueous Ni2+ in 2% agarose varied between 0.66â¯s-1â¯mM-1 at 3â¯T and 0.94â¯s-1â¯mM-1 at 11.7T. INTERPRETATION: While several factors affect the reproducibility of R1-based MR biomarkers measured preclinically, between-centre propagation of errors arising from intrinsic equipment irreproducibility should in most cases be small. However, in a few specific cases exceptional efforts might be required to ensure R1-reproducibility.
Assuntos
Processamento de Imagem Assistida por Computador/métodos , Imageamento por Ressonância Magnética , Imagens de Fantasmas , Sefarose/química , Água/química , Animais , Biomarcadores , Simulação por Computador , Camundongos , Níquel/química , Oxigênio , Prótons , Ratos , Análise de Regressão , Reprodutibilidade dos TestesRESUMO
The monitoring of diabetes mellitus, as it develops and becomes clinically evident, remains a major challenge for diagnostic imaging in clinical practice. Here we present a novel approach to beta-cell imaging by targeting the sulphonylurea receptor subtype 1 (SUR1), using multivalent derivatives of the anti-diabetic drug glibenclamide. Since glibenclamide has a high affinity for SUR1 but does not contain a suitable functional group to be linked to an imaging probe, we have synthesized 11 glibenclamide derivatives and evaluated their affinity to SUR1 in MIN6 cells. The most promising compound has been used to obtain multivalent glibenclamide-polyamidoamine (PAMAM) derivatives, containing up to 15 sulphonylurea moieties per dendrimer. The remaining functional groups on the dendrimers can consecutively be used for labeling with reporter groups for different imaging modalities, thus allowing for multifunctional imaging, and for the modification of pharmacokinetic properties. We synthesized fluorochrome-labeled multivalent probes, that demonstrate in cellular assays affinities to SUR1 in the nanomolar range, superior to native glibenclamide. The probes specifically label MIN6 cells, but not HeLa or PANC-1 cells which do not express SUR1. A very low cytotoxicity of the multivalent probes is demonstrated by the persistent release of insulin from MIN6 cells exposed to high glucose concentrations. Furthermore, the probes display positive labeling of beta-cells of primary mouse and human islet-cells ex vivo and of islets of Langerhans in vivo. The data document that multivalent probes based on glibenclamide derivatives provide a suitable platform for further developments of cell-specific probes, and can be adapted for multiple imaging modalities, including those that are now used in the clinics.
Assuntos
Diagnóstico por Imagem , Glibureto/farmacologia , Ilhotas Pancreáticas/metabolismo , Sondas Moleculares/química , Animais , Morte Celular/efeitos dos fármacos , Dendrímeros/química , Corantes Fluorescentes/síntese química , Corantes Fluorescentes/química , Glibureto/síntese química , Glibureto/química , Células HeLa , Humanos , Ilhotas Pancreáticas/efeitos dos fármacos , Ligantes , Camundongos , Microscopia Confocal , Especificidade de Órgãos/efeitos dos fármacos , Receptores de Sulfonilureias/metabolismoRESUMO
Insulin resistance plays an important role in the pathogenesis of human type 2 diabetes. In humans, a negative correlation between insulin sensitivity and intramyocellular lipid (IMCL) content has been shown; thus, IMCL becomes a marker for insulin resistance. Recently, magnetic resonance spectroscopy (MRS) has been established as a dependable method for selective detection and quantification of IMCL in humans. To validate the interrelation between insulin sensitivity and IMCL in an animal model of type 2 diabetes, we established volume selective (1)H-MRS at 7 Tesla to noninvasively assess IMCL in the rat. In male obese Zucker Diabetic Fatty rats and their lean littermates, IMCL levels were determined repeatedly over 4 months, and insulin sensitivity was measured by the euglycemic-hyperinsulinemic clamp method at 6-7 and at 22-24 weeks of age. A distinct relation between IMCL and insulin sensitivity was demonstrated as well as age dependence for both parameters. Rosiglitazone treatment caused a clear reduction of IMCL and hepatic fat despite increased body weight, and a marked improvement of insulin sensitivity. Thus, the insulin sensitizing properties of rosiglitazone were consistent with a redistribution of lipids from nonadipocytic (skeletal muscle, liver) back into fat tissue.
Assuntos
Diabetes Mellitus/metabolismo , Diabetes Mellitus/fisiopatologia , Resistência à Insulina/fisiologia , Metabolismo dos Lipídeos , Músculo Esquelético/metabolismo , Obesidade , Tiazolidinedionas , Tecido Adiposo/patologia , Animais , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatologia , Fígado/patologia , Estudos Longitudinais , Espectroscopia de Ressonância Magnética , Masculino , Músculo Esquelético/efeitos dos fármacos , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Zucker/genética , Receptores Citoplasmáticos e Nucleares/agonistas , Rosiglitazona , Tiazóis/farmacologia , Fatores de Transcrição/agonistasRESUMO
Increased supply of fatty acids to muscle and liver is causally involved in the insulin resistance syndrome. Using a tissue microdialysis technique in Wistar and Zucker fatty (ZF) rats, we determined tissue glycerol levels as a marker of lipolysis in gastrocnemius muscle (gMT), subcutaneous adipose (SAT), and visceral adipose tissue (VAT) as well as the reduction of plasma free fatty acids, glycerol, and triglycerides caused by the antilipolysis-specific adenosine-A1 receptor agonist (ARA). In Wistar and ZF rats, ARA significantly lowered dialysate glycerol levels in SAT, VAT, and gMT. Whereas in SAT and VAT the decrease in dialysate glycerol indicated adipocytic antilipolysis, this decrease in gMT was not caused by a direct effect of ARA on intramyocellular lipolysis, as demonstrated by the lack of inhibition of the protein kinase A activity ratio in gMT. In addition, no differences of the fed-starved-refed dynamics of intramyocellular triglyceride levels compared with untreated controls were measured by in vivo (1)H-spectroscopy, excluding any adenylate cyclase-independent antilipolysis in muscle. Treatment with ARA resulted in pronounced reductions of plasma free fatty acids, glycerol, and triglycerides. Furthermore, in ZF rats, ARA treatment caused an immediate improvement of peripheral insulin sensitivity measured by the euglycemic-hyperinsulinemic glucose clamp technique.
Assuntos
Lipólise , Obesidade/metabolismo , Receptor A1 de Adenosina/metabolismo , Tecido Adiposo/metabolismo , Animais , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Ácidos Graxos não Esterificados/sangue , Técnica Clamp de Glucose , Glicerol/sangue , Glicerol/metabolismo , Espectroscopia de Ressonância Magnética , Masculino , Microdiálise , Músculo Esquelético/metabolismo , Ratos , Ratos Wistar , Ratos Zucker , Tela Subcutânea/metabolismo , Triglicerídeos/sangue , VíscerasRESUMO
The physiological dynamics of intramyocellular lipids (IMCLs) in different muscle types and of hepatocellular lipids (HepCLs) are still uncertain. The dynamics of IMCLs in the soleus, tibialis anterior, and extensor digitorum longus (EDL) muscles and HepCL during fed, 12- to 72-h starved, and refed conditions were measured in vivo by (1)H-magnetic resonance spectroscopy (MRS) in Wistar rats. Despite significant elevations of free fatty acids (FFAs) during starvation, HepCLs and IMCLs in soleus remained constant. In tibialis anterior and EDL, however, IMCLs increased significantly by 170 and 450% after 72 h of starvation, respectively. After refeeding, elevated IMCLs dropped immediately in both muscles. Total muscle long-chain acyl-CoAs (LCACoAs) remained constant during the study period. Hepatic palmitoleoyl-CoA (C16:1) decreased significantly during starvation while total hepatic LCACoAs increased significantly. Consistent with constant values for FFAs, HepCLs, IMCLs, and muscle LCACoAs from 12-72 h of starvation, insulin sensitivity did not change. We conclude that during starvation-induced adipocytic lipolysis, oxidative muscles dispose elevated FFAs by oxidation, while nonoxidative ones neutralize FFAs by reesterification. Both mechanisms might prevent impairment of insulin signaling by maintaining low levels of LCACoAs. Hepatic palmitoleoyl-CoA might have a special role in lipid metabolism due to its unique dynamic profile during starvation.
Assuntos
Metabolismo dos Lipídeos , Glicogênio Hepático/metabolismo , Fígado/metabolismo , Músculo Esquelético/metabolismo , Inanição/metabolismo , Animais , Glicemia/metabolismo , Técnica Clamp de Glucose , Masculino , Especificidade de Órgãos , Ratos , Ratos Wistar , Fatores de Tempo , Triglicerídeos/metabolismoRESUMO
BACKGROUND: Hypertension and metabolic syndrome (MetS) are associated with increased sympathetic activation possibly contributing to the progression of renal damage and cardiac remodeling. Renal sympathetic denervation (RDN) decreases sympathetic renal efferent and afferent nerve activity. METHODS: Obese spontaneously hypertensive rats (SHRs-ob) were subjected to RDN at the age of 34 weeks (SHRs-ob + RDN) and were compared with sham-operated SHRs-ob and their normotensive lean controls (Ctrs). Blood pressure was measured by telemetry. Kidney and heart function were determined by magnetic resonance imaging (MRI). Renal and cardiac remodeling were characterized by immunohistochemical analyses. Animals were killed at the age of 48 weeks. RESULTS: In SHRs-ob, RDN attenuated the progressive increase in blood pressure and preserved a mean blood pressure of 156±7mm Hg compared with 220±8mm Hg in sham-operated SHRs-ob at 100 days after RDN, whereas heart rate, body weight, and metabolic parameters remained unchanged. Renal catecholamine and tyrosine hydroxylase levels were significantly reduced after RDN, suggesting effective renal denervation. Progression of renal dysfunction as characterized by increased urinary albumin/creatinine ratio and reduced glomerular filtration rate were attenuated by RDN. In SHRs-ob, renal perfusion was significantly reduced and normalized by RDN. Cardiac fibrosis and cardiac diastolic dysfunction measured by MRI and invasive pressure measurements were significantly attenuated by RDN. CONCLUSIONS: In SHRs-ob, progressive increase in blood pressure and progression of renal injury and cardiac remodelling are mediated by renal sympathetic activation as they were attenuated by RDN.
Assuntos
Injúria Renal Aguda/metabolismo , Pressão Sanguínea , Hipertensão/fisiopatologia , Rim/inervação , Miocárdio/patologia , Obesidade/fisiopatologia , Insuficiência Renal Crônica/metabolismo , Remodelação Ventricular , Injúria Renal Aguda/etiologia , Animais , Creatinina/metabolismo , Progressão da Doença , Hipertensão/complicações , Rim/fisiopatologia , Imageamento por Ressonância Magnética , Masculino , Obesidade/complicações , Ratos , Ratos Endogâmicos SHR , Ratos Sprague-Dawley , Insuficiência Renal Crônica/etiologia , Simpatectomia , Sistema Nervoso SimpáticoRESUMO
Osteoarthritis (OA) is one of the most common diseases in the aging population. While disease progress in humans is monitored indirectly by X-ray or MRI, small animal OA lesions detection always requires surgical intervention and histology. Here we introduce bimodal MR/NIR probes based on cartilage-targeting 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid amide (DOTAM) that are directly administered to the joint cavity. We demonstrate applications in healthy and diseased rat joints by MRI in vivo. The same joints are inspected post-mortem by fluorescence microscopy, showing not only the precise location of the reagents but also revealing details such as focal cartilage damage and chondrophyte or osteophyte formation. This allows for determining the distinct pathological state of the disease and the regeneration capability of the animal model and will help to correctly assess the effect of potential disease modifying OA drugs (DMOADs) in the future.
RESUMO
The neuroprotective activity of ACEA 1021 (5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione; licostinel), a selective antagonist at the strychnine-insensitive glycine site associated with the NMDA receptor complex, has been investigated in various models of focal cerebral ischemia. In isoflurane-anaesthesised Wistar rats with permanent ipsilateral carotid artery ligation and transient middle cerebral artery occlusion (duration of occlusion, 2 h) followed by reperfusion (24 h), intravenous administration of ACEA 1021 (bolus: 10 mg/kg, 15 min after the onset of middle cerebral artery occlusion; infusion: 7 mg/kg/h for 6 h beginning 30 min after occlusion of the artery) produced a 32% reduction in infarct volume. Similarly, in Sprague-Dawley rats with transient middle cerebral artery occlusion (2 h) followed by 24 h of reperfusion, identical treatment with ACEA 1021 decreased infarct size by 39%. Magnetic resonance imaging (MRI) confirmed these effects in the transient model, in that infarct volume observed using apparent diffusion coefficient (ADC) maps was significantly smaller after 24 h in the ACEA 1021-treated rats compared with Tris-treated controls. Furthermore, the increase in perfusion signal intensity after reperfusion was more pronounced in the ACEA 1021-treated rats than in controls. In Fisher 344 rats with permanent occlusion of the middle cerebral artery, ACEA 1021 induced a dose-related decrease in infarct volume, which was associated with an improvement in neurological outcome as measured by the rope suspension procedure. Administration of the same dose regimen, as above, in Fisher rats with permanent middle cerebral artery occlusion reduced infarct volume by 68%. This dose was as effective when administration was delayed for 2 h. In mice with permanent middle cerebral artery occlusion, ACEA 1021 (5 mg/kg, i.v., 5 min after occlusion; 30 mg/kg, s.c., 1 and 4 h post-middle cerebral artery occlusion) decreased infarct size by 42%. The consistent anti-ischemic effects of ACEA 1021 make it a valuable compound for exploratory stroke research.
Assuntos
Infarto Encefálico/tratamento farmacológico , Isquemia Encefálica/tratamento farmacológico , Encéfalo/patologia , Fármacos Neuroprotetores/uso terapêutico , Quinoxalinas/uso terapêutico , Animais , Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Infarto Encefálico/etiologia , Infarto Encefálico/patologia , Isquemia Encefálica/complicações , Isquemia Encefálica/patologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Injeções Intravenosas , Injeções Subcutâneas , Imageamento por Ressonância Magnética , Masculino , Camundongos , Fármacos Neuroprotetores/administração & dosagem , Desempenho Psicomotor/efeitos dos fármacos , Quinoxalinas/administração & dosagem , Ratos , Ratos Endogâmicos F344 , Ratos Sprague-Dawley , Ratos Wistar , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , ReperfusãoRESUMO
This review summarizes the current knowledge on anatomy and physiology of the human gastrointestinal tract in comparison with that of common laboratory animals (dog, pig, rat and mouse) with emphasis on in vivo methods for testing and prediction of oral dosage form performance. A wide range of factors and methods are considered in addition, such as imaging methods, perfusion models, models for predicting segmental/regional absorption, in vitro in vivo correlations as well as models to investigate the effects of excipients and the role of food on drug absorption. One goal of the authors was to clearly identify the gaps in today's knowledge in order to stimulate further work on refining the existing in vivo models and demonstrate their usefulness in drug formulation and product performance testing.
Assuntos
Biofarmácia/métodos , Excipientes/química , Interações Alimento-Droga , Trato Gastrointestinal/metabolismo , Absorção Intestinal , Preparações Farmacêuticas/metabolismo , Farmacocinética , Administração Oral , Animais , Química Farmacêutica , Motilidade Gastrointestinal , Humanos , Modelos Animais , Modelos Biológicos , Preparações Farmacêuticas/administração & dosagem , Preparações Farmacêuticas/química , Reprodutibilidade dos Testes , Especificidade da EspécieRESUMO
AIMS: Type 2 diabetes mellitus (DM) leads to cardiac dysfunction irrespective of hypertension and coronary artery disease; this is called diabetic cardiomyopathy. Here, we investigated the severity of diabetic cardiomyopathy and myocardial remodelling in aged Zucker diabetic fatty (ZDF) rats. METHODS AND RESULTS: Body weight, blood glucose and glycated haemoglobin (Hb(A1c)) levels, and urinary albumin excretion were monitored regularly in ZDF rats (n = 19) and control littermates (n = 19) up to age 45 weeks. ZDF rats were severely diabetic during the entire study period and demonstrated decreased body and heart weights at sacrifice. Left ventricular (LV) function was determined using magnetic resonance imaging (MRI) at age 44 weeks and revealed similar LV ejection fraction and cardiac output index in control and ZDF rats, indicating preserved systolic function. LV pressure characteristics assessed at age 45 weeks showed significant, but mild elevations of LV end-diastolic pressure (+45%) and relaxation time constant Tau (+54%) in ZDF rats, indicating diastolic dysfunction. Histological analyses revealed a significantly increased LV collagen content (+50%), but no cardiomyocyte hypertrophy in ZDF rats. CONCLUSION: The present study clearly shows that long term, severe DM in 45-week-old ZDF rats resulted in relatively mild impairment of diastolic LV function, whereas systolic function was well preserved. These data do not support the notion that diabetes per se is a critical factor in the induction of a clinically relevant degree of cardiac dysfunction. Co-morbidities such as hypertension and coronary artery disease probably have larger impacts on myocardial function in diabetic individuals.
Assuntos
Diabetes Mellitus Tipo 2/complicações , Cardiomiopatias Diabéticas/fisiopatologia , Disfunção Ventricular Esquerda/fisiopatologia , Remodelação Ventricular , Animais , Cardiomiopatias Diabéticas/etiologia , Diástole , Masculino , Ratos , Ratos Zucker , Disfunção Ventricular Esquerda/etiologiaRESUMO
This is the first study to examine the effect of subchronic olanzapine (OLZ) on energy homeostasis in rats, covering all aspects of energy balance, including energy intake as metabolizable energy, storage, and expenditure. We further analyzed whether, and by which mechanism, the CB1-antagonist AVE1625 might attenuate OLZ-induced body weight gain. For this purpose, we selected juvenile female Hanover Wistar rats that robustly and reproducibly demonstrated weight gain on OLZ treatment, accepting limitations to model the aberrations on lipid and carbohydrate metabolism. Rats received 2 mg/kg OLZ orally twice daily for 12 days. Body weight and body composition were analyzed. Moreover daily food intake, energy expenditure, and substrate oxidation were determined in parallel to motility and body core temperature. OLZ treatment resulted in substantial body weight gain, in which lean and fat mass increased significantly. OLZ-treated rats showed hyperphagia that manifested in increased carbohydrate oxidation and lowered fat oxidation (FO). Energy expenditure was increased, motility decreased, but there was no indication for hypothermia in OLZ-treated rats. Coadministration of OLZ and AVE1625 (10 mg/kg orally once daily) attenuated body weight gain, diminishing the enhanced food intake while maintaining increased energy expenditure and decreased motility. Our data reveal that energy expenditure was enhanced in OLZ-treated rats, an effect not critically influenced by motility. Energy uptake, however, exceeded energy expenditure and led to a positive energy balance, confirming hyperphagia as the major driving factor for OLZ-induced weight gain. Combination of OLZ treatment with the CB1-antagonist AVE1625 attenuated body weight gain in rats.
Assuntos
Fármacos Antiobesidade/uso terapêutico , Antipsicóticos/efeitos adversos , Benzodiazepinas/efeitos adversos , Metabolismo Energético/efeitos dos fármacos , Hidrocarbonetos Halogenados/uso terapêutico , Receptor CB1 de Canabinoide/antagonistas & inibidores , Sulfonamidas/uso terapêutico , Aumento de Peso/efeitos dos fármacos , Animais , Fármacos Antiobesidade/administração & dosagem , Fármacos Antiobesidade/farmacologia , Antipsicóticos/administração & dosagem , Benzodiazepinas/administração & dosagem , Carboidratos da Dieta/metabolismo , Gorduras na Dieta/metabolismo , Ingestão de Energia/efeitos dos fármacos , Feminino , Hidrocarbonetos Halogenados/administração & dosagem , Hidrocarbonetos Halogenados/farmacologia , Hiperfagia/tratamento farmacológico , Hiperfagia/etiologia , Hiperfagia/metabolismo , Obesidade/etiologia , Obesidade/metabolismo , Obesidade/prevenção & controle , Olanzapina , Oxirredução , Ratos , Ratos Wistar , Sulfonamidas/administração & dosagem , Sulfonamidas/farmacologiaRESUMO
The mitochondrial pyruvate dehydrogenase complex (PDC) is inactivated in many tissues during starvation and diabetes. We investigated carbohydrate oxidation (CHO) and the regulation of the PDC in lean and obese Zucker diabetic fatty (ZDF) rats during fed and starved conditions as well as during an oral glucose load without and with pharmacologically reduced levels of free fatty acids (FFA) to estimate the relative contribution of FFA on glucose tolerance, CHO, and PDC activity. The increase in total PDC activity (20-45%) was paralleled by increased protein levels ( approximately 2-fold) of PDC subunits in liver and muscle of obese ZDF rats. Pyruvate dehydrogenase kinase-4 (PDK4) protein levels were higher in obese rats, and consequently PDC activity was reduced. Although PDK4 protein levels were rapidly downregulated (57-62%) in both lean and obese animals within 2 h after glucose challenge, CHO over 3 h as well as the peak of PDC activity (1 h after glucose load) in liver and muscle were significantly lower in obese rats compared with lean rats. Similar differences were obtained with pharmacologically suppressed FFA by nicotinic acid, but with significantly improved glucose tolerance in obese rats, as well as increased CHO and delta increases in PDC activity (0-60 min) both in muscle and liver. These results demonstrated the suppressive role of FFA acids on the measured parameters. Furthermore, the results clearly demonstrate a rapid reactivation of PDC in liver and muscle of lean and obese rats after a glucose load and show that PDC activity is significantly lower in obese ZDF rats.
Assuntos
Diabetes Mellitus Tipo 2/metabolismo , Resistência à Insulina/fisiologia , Obesidade/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Complexo Piruvato Desidrogenase/metabolismo , Animais , Glicemia/metabolismo , Ácidos Graxos não Esterificados/metabolismo , Teste de Tolerância a Glucose , Hiperinsulinismo/metabolismo , Masculino , Oxirredução , Piruvato Desidrogenase Quinase de Transferência de Acetil , Ratos , Ratos Zucker , Inanição/metabolismoRESUMO
Intramyocellular lipid content (IMCL) serves as a good biomarker of skeletal muscle insulin resistance (IR). However, intracellular fatty acid metabolites [malonyl-CoA, long-chain acyl-CoA (LCACoA)] rather than IMCL are considered to be responsible for IR. This study aimed to investigate dynamics of IMCL and fatty acid metabolites during fed-to-starved-to-refed transition in lean and obese (IR) Zucker diabetic fatty rats in the following different muscle types: soleus (oxidative), extensor digitorum longus (EDL, intermediary), and white tibialis anterior (wTA, glycolytic). In the fed state, IMCL was significantly elevated in obese compared with lean rats in all three muscle types (soleus: 304%, EDL: 333%, wTA: 394%) in the presence of elevated serum triglycerides but similar levels of free fatty acids (FFA), malonyl-CoA, and total LCACoAs. During starvation, IMCL in soleus remained relatively constant, whereas in both rat groups IMCL increased significantly in wTA and EDL after comparable dynamics of starvation-induced FFA availability. The decreases of malonyl-CoA in wTA and EDL during starvation were more pronounced in lean than in obese rats, although there were no changes in soleus muscles for both groups. The concomitant increase in IMCL with the fall of malonyl-CoA support the concept that, as a reaction to starvation-induced FFA availability, muscle will activate lipid oxidation more the lower its oxidative capacity and then store the rest as IMCL.
Assuntos
Ácidos Graxos/metabolismo , Resistência à Insulina/fisiologia , Músculo Esquelético/metabolismo , 3-Hidroxiacil-CoA Desidrogenases/metabolismo , Animais , Glicemia/metabolismo , Peso Corporal/fisiologia , Ácidos Graxos/análise , Ácidos Graxos não Esterificados/sangue , Ácidos Graxos Insaturados/análise , Técnica Clamp de Glucose , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Glicogênio Fosforilase/metabolismo , Hexoquinase/metabolismo , Insulina/sangue , Corpos Cetônicos/sangue , Lipídeos/análise , Masculino , Malonil Coenzima A/metabolismo , Fibras Musculares de Contração Rápida/química , Fibras Musculares de Contração Rápida/enzimologia , Fibras Musculares de Contração Rápida/metabolismo , Fibras Musculares de Contração Lenta/química , Fibras Musculares de Contração Lenta/enzimologia , Fibras Musculares de Contração Lenta/metabolismo , Músculo Esquelético/química , Músculo Esquelético/enzimologia , Ratos , Ratos Zucker , Triglicerídeos/sangueRESUMO
Lactacidosis is a common feature of ischaemic brain tissue, but its role in ischaemic neuropathology is still not fully understood. Na(+)/H(+) exchange, a mechanism involved in the regulation of intracellular pH (pH(i)), is activated by low pH(i). The role of Na(+)/H(+) exchange subtype 1 was investigated during extracellular acidification and subsequent pH recovery in the absence and presence of (4-isopropyl-3-methylsulphonyl-benzoyl)-guanidine methanesulfonate (HOE642, Cariporid), a new selective and powerful inhibitor of the Na(+)/H(+) exchanger subtype 1 (NHE-1). It was compared for normoxia and hypoxia in two glioma cell lines (C6 and F98). pH(i) was monitored by fluorescence spectroscopy using the intracellularly trapped pH-sensitive dye 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF). Alterations in glial cell metabolism were characterized using high-resolution (1)H, (13)C and (31)P NMR spectroscopy of perchloric acid extracts. NHE-1 contributed to glial pH regulation, especially at pathologically low pH(i) values. NHE-1 inhibition with HOE642 during acidification caused exacerbated metabolic disorders which were prolonged during extracellular pH recovery. However, NHE-1 inhibition during hypoxia protected the energy state of glial cells.
Assuntos
Ácidos/metabolismo , Neoplasias Encefálicas/metabolismo , Espaço Extracelular/metabolismo , Glioma/metabolismo , Hipóxia/metabolismo , Trocadores de Sódio-Hidrogênio/metabolismo , Animais , Neoplasias Encefálicas/patologia , Glioma/patologia , Concentração de Íons de Hidrogênio , Líquido Intracelular/metabolismo , Ratos , Células Tumorais CultivadasRESUMO
OBJECTIVE: In this longitudinal MR study the early stages of joint pathology in two surgically-induced rabbit models of osteoarthritis (OA) were monitored by in vivo contrast-enhanced MRI at 7.1T. Qualitative and quantitative MR data were compared with macroscopic and microscopic findings. METHOD: Scanning of mature, male New Zealand White rabbits (N=12) was performed before surgery, and at 2, 4, and 8 weeks after unilateral transection of the anterior cruciate ligament (ACLT), medial meniscectomy (ME), or sham operation. MR-images were simultaneously obtained of both knee joints after intravenous injection of Magnevist. We implemented a 2D T1-weighted (T1w) coronal, fat-saturated gradientecho protocol (68 x 138 microm2, slice thickness 1 mm). Additionally, consecutive 3D gradientecho images were obtained from two sham-operated and two rabbits of the ME group (234 x 273 x 234 microm(3)). ACLT animals were sacrificed at 2 weeks (N=1), and 8 weeks (N=3), ME animals were sacrificed at 4 weeks (N=2), and 8 weeks (N=4), and sham-operated animals were sacrificed at 2 weeks (N=1) and 8 weeks (N=1), respectively. RESULTS: Both OA models reflected important characteristics of the clinical picture of OA. With MR we were able to monitor time dependently the decline of synovial effusion and the formation of osteophytes. Morphologic MR examination showed a moderate to high accuracy for detecting synovial effusion (75%), meniscus (86%) and cruciate ligament (91%) lesions, and osteophytes (88%) as assessed by macroscopic examination. False-negative MR findings for gross macroscopic changes were due to the relative high slice thickness in 2D scans and the fact that the slices only covered the main weightbearing area of the femorotibial joint. Contour abnormalities of articular cartilage were not reliably detected. Quantitative analysis revealed a statistically significant increase of cartilage signal intensity in medial tibial cartilage (48+/-9% ACLT, and 29+/-9% ME in 2D datasets) as compared to contralateral control knees in two-week scans. Signal enhancement persisted or increased at later dates. CONCLUSION: With high-resolution contrast-enhanced MRI at 7.1T the time course of gross pathologic changes in rabbit knees with surgically induced OA can be monitored. Still insufficient spatial resolution and image contrast of the applied 2D protocols limit the sensitivity and prohibit detection of articular cartilage contour abnormalities. However, signal alterations in the cartilage layer indicate alterations of tissue composition at a very early stage of OA development. When used with 3D protocols, contrast-enhanced MRI offers a promising tool for qualitative and quantitative in vivo monitoring of OA in rabbit models.
Assuntos
Imageamento por Ressonância Magnética/métodos , Osteoartrite do Joelho/patologia , Animais , Ligamento Cruzado Anterior/patologia , Cartilagem Articular/patologia , Modelos Animais de Doenças , Gadolínio DTPA , Membro Posterior , Aumento da Imagem/métodos , Articulações/patologia , Masculino , Meniscos Tibiais/patologia , Coelhos , Líquido SinovialRESUMO
The investigation of intramyocellular lipids (IMCLs) with proton MR spectroscopy ((1)H-MRS) in humans has recently received increasing attention. IMCL levels correlate with insulin resistance and are affected by diet and exercise, making IMCL an interesting marker for metabolic investigations. In the present in vivo study, the feasibility of using (1)H MRS for the detection of IMCL in rats is demonstrated, and the influence of various factors, such as age, gender, muscle type, and rat strain, on IMCL levels is systematically analyzed. In healthy Wistar and Sprague Dawley (SD) rats, the highest ratios of IMCL/tCr were found in young rats, and IMCL/tCr decreased with increasing age. In addition, IMCL concentration was clearly influenced by gender and muscle type. Insulin-resistant, male, obese, Zucker diabetic fatty (ZDF) rats showed significantly higher IMCL levels than Wistar or SD rats. In conclusion, although IMCL levels are clearly influenced by insulin resistance, several other factors influence IMCL levels, such as age, gender, muscle type, and rat strain. Therefore, when using IMCL as a surrogate marker for insulin resistance, it is necessary to carefully compare results with age- and gender-matched controls, and to use identical conditions.